Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non–Small Cell Lung Carcinogenesis
Tianshun Zhang(Hong Kong Polytechnic University), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Qingxin Xia(Zhengzhou University), Ann M. Bode(University of Minnesota), Qiushi Wang(Hormel (United States)), Ting Wang(Jilin University), Xiang Li(Nanjing University of Chinese Medicine), Keke Wang(Hebei Medical University), Ruihua Bai(Institute of Soil and Water Conservation), Yongping Song(Zhengzhou University), Joohyun Ryu(University of Minnesota), Kangdong Liu(Zhengzhou University), Weiya Ma(University of Minnesota), Xiaoyu Chang
Cited by 32
Related Papers
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|390
Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
|Proceedings of the National Academy of Sciences|1998|201
Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway
|Acta Pharmacologica Sinica|2016|182
Emerging agents that target signaling pathways in cancer stem cells
|Journal of Hematology & Oncology|2020|176